Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2003
11/12/2003EP0817650B1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/12/2003EP0804163B1 Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof
11/12/2003EP0790060B1 Substance ameliorant le metabolisme des graisses
11/12/2003EP0775203B1 Method of gene therapy using dna vectors without selection marker gene
11/12/2003EP0768892B1 Thrombolytic composition
11/12/2003EP0759759B1 P75 tnf receptor promoters
11/12/2003EP0752987B1 Pyrimidinyl derivatives as interleukin inhibitors
11/12/2003EP0752883B1 Use of mcp-1 for inducing ripening of the cervix
11/12/2003EP0513336B1 New variants derived from interferons of type i, production process thereof and their applications
11/12/2003CN1455781A Discrimination between GnRH-Ôàáand GnRH-Ôàí"
11/12/2003CN1455780A New retinol derivatives, method of preparation and uses thereof
11/12/2003CN1455682A Compositions for gene therapy of rheumatoid arthritis including gene encoding anti-angiogenic protein or parts thereof
11/12/2003CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom
11/12/2003CN1455679A Use of melagatran for manufacture of medicament for treatment of ischemic disorders
11/12/2003CN1455678A Methods of therapy with thrombin derived peptides
11/12/2003CN1455677A Skin wound healing promoters
11/12/2003CN1454667A Convenient fibrin blocking agent
11/12/2003CN1454666A Medicine composition, preparing method thereof and its use for preparing medicines for curing SARS and SARS-induced cardio-cerebro complication
11/12/2003CN1454588A Polypeptide protein oral nano particle preparation
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127515C Process for preparing certain AzA
11/12/2003CN1127514C Antineoplastic peptides
11/12/2003CN1127513C Phosphonic acid derivatives with metallopeptidase inhibitory activity
11/12/2003CN1127512C Acylated enol derivatives of alpha-ketoesters and alpha-ketoamides
11/12/2003CN1127511C Inhibitors of interleukin-1 ÔÇ£betaÔÇØ converting enzyme
11/12/2003CN1127510C Prodrugs of thrombin inhibitors
11/12/2003CN1127497C Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
11/12/2003CN1127352C CCK antibodies used to improve feed efficiency
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/12/2003CN1127350C Cyclosorin-containing soft capsule preparations
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6647191 Optical fiber with large effective area, low dispersion and low dispersion slope
11/11/2003US6646110 G-CSF polypeptides and conjugates
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646006 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
11/11/2003US6646004 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
11/11/2003US6645995 Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
11/11/2003US6645948 Nutritional composition for the treatment of connective tissue
11/11/2003US6645945 Method of treating diseased, injured or abnormal cartilage with hyaluronic acid and growth factors
11/11/2003US6645944 Antiproliferative and anticarcinogenic agents; gene therapy
11/11/2003US6645938 Protection against ischemia and reperfusion injury
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645936 Administering ophthalmic lactoferrin solution to eyes of patient after sclerocorneal incision as wound healing agent
11/11/2003US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof
11/11/2003US6645934 Peptide with radio protective effect
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645770 Predicting sensitivity of prostate cancer
11/11/2003US6645736 Calcium independent cytosolic phospholipase A2/B enzymes
11/11/2003US6645522 Erythropoietin or derivatives that cause bone marrow cells to increase production of reticulocytes and erythrocytes; hydrogenated lecithin that may be hydrogenated; cholesterol or a derivative; phosphate buffer
11/11/2003US6645513 Treatment of skin with adenosine or adenosine analog
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645504 Certain antigens (called "bystander antigens" and defined below) causes T-cells to be elicited that in turn suppress cells that contribute to immune attack of the organ or tissue involved in an autoimmune disease
11/11/2003US6645501 Anti-pathogen system and methods of use thereof
11/11/2003US6645500 Method for down-regulating osteoprotegerin ligand activity
11/11/2003US6645496 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion by administering Botulinum toxin type A
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645490 Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
11/11/2003US6645487 Method for stimulating an immune response
11/11/2003US6645485 Method of treating inflammation in the joints of a body
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003US6645469 Method for dispensing S-adenosyl-methionine in a micro fine powdered form by inhalation
11/11/2003US6645468 Medicinal aerosol formulation
11/11/2003US6645466 Dry powder for inhalation
11/11/2003US6645168 Decreasing postoperative analgesic opiate requirement; reducing operating site time for patient
11/11/2003US6644320 Treatment of hepatitis C using hyperthermia
11/11/2003CA2264268C Novel peptide derivatives having thiazolyl-alanine residue
11/11/2003CA2185932C Use of a least one peptide in a cosmetic composition or for the preparation of a drug
11/11/2003CA2120477C A device for the even application of a suspension to a collagen carrier
11/11/2003CA2104636C Use of kallikrein inhibitor for the production of a pharmaceutical for the prophylaxis and therapy of certain diseases
11/06/2003WO2003091456A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003WO2003091434A1 Novel protein and dna thereof
11/06/2003WO2003091432A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003WO2003091429A1 Antimicrobial polypeptide and utizliation thereof
11/06/2003WO2003091419A2 Kinases and phosphatases
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091403A2 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/06/2003WO2003091400A2 Contraceptive targets
11/06/2003WO2003091395A2 Inhibition of immune complex formation
11/06/2003WO2003091390A2 Regulation of gene expression by neuromodulators and discovery of a novel ngf-induced protein termed pincher
11/06/2003WO2003091387A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands
11/06/2003WO2003091384A2 A role for survivin in apoptosis of myeloid cells
11/06/2003WO2003091278A1 Gamma-secretase inhibitors
11/06/2003WO2003091275A2 Compositions containing anti-hiv peptides and methods of use
11/06/2003WO2003091274A2 Use of alpha-s2 casein precursor-derived peptided
11/06/2003WO2003091271A1 Alternatively spliced nucleic acid molecules
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090870A1 Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
11/06/2003WO2003090868A1 Method and apparatus for ultrasound treatment of connective tissue
11/06/2003WO2003090800A1 Wound dressings comprising hydrated hydrogels and enzymes
11/06/2003WO2003090788A1 DECOY FOR TREATING AND/OR PREVENTING Th2 CYTOKINE-ASSOCIATED ALLERGIC DISEASE, GATA3 MUTANT PROTEIN AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
11/06/2003WO2003090785A1 Methods and conpositions for treating, preventing or delaying onset of a neoplasm
11/06/2003WO2003090784A1 Treatment of metabolic syndrome
11/06/2003WO2003090783A1 Preventive/remedy for diabetes
11/06/2003WO2003090778A2 Dna vaccine combined with an inducer of tumor cell apoptosis
11/06/2003WO2003090777A1 Combination therapy to treat a catabolic state in a patient
11/06/2003WO2003090776A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders
1 ... 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 ... 3163